|1.||Luo, Weiming: 1 article (07/2010)|
|2.||Holloway, Harold W: 1 article (07/2010)|
|3.||Greig, Nigel H: 1 article (07/2010)|
|4.||Lahiri, Debomoy K: 1 article (07/2010)|
|5.||Yu, Qian-Sheng: 1 article (07/2010)|
|6.||Brossi, Arnold: 1 article (07/2010)|
|7.||Lin, Gialih: 1 article (07/2005)|
|8.||Lee, Yu-Ru: 1 article (07/2005)|
|9.||Wu, Yon-Gi: 1 article (07/2005)|
|10.||Liu, Yu-Chen: 1 article (07/2005)|
|1.||Alzheimer Disease (Alzheimer's Disease)
07/01/2005 - "Phenyl carbamates are used to treat Alzheimer's disease. "
02/01/2002 - "In order to develop new cholinesterase agents effective against Alzheimer's disease (AD) we synthesized some phenylcarbamates structurally related to Rivastigmine and evaluated their in vitro and in vivo biological activity. "
02/01/2002 - "Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease."
07/01/2003 - "Results of this study suggest a potential role of phenylcarbamates as alternative to benzimidazoles in the therapy of giardiasis."
11/01/2004 - "The results described here suggest a potential role for a combined therapy with phenyl-carbamates and sub-doses of benzimidazoles in the treatment of giardiasis."
08/01/1985 - "The N-phenyl carbamates were much less active against P-388 than the phenyl carbamates; only bis-N-phenyl carbamates with a methylene bridge between the two phenyl groups showed good activity against both P-388 and L-1210 leukemias. "
08/01/1985 - "Except for the mycophenolic acid carbamates, the fused phenyl carbamates showed poor activity against both P-388 and L-1210 leukemias. "
|4.||Pyridostigmine Bromide (Pyridostigmine)
|6.||Neostigmine (Neostigmine Bromide)
|8.||Cholinesterase Inhibitors (Anticholinesterases)